ArticleFungal biology and biotechnology2022
Establishment of the basidiomycete Fomes fomentarius for the production of composite materials.
Article in Fungal biology and biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Tensile characterization and life cycle assessment of fungal-colonized 3D-printed PLA/wood biocomposites.Scientific reports · 2026Article
- Maximization of bioactive potential of Fomes fomentarius via artificial Intelligence-Assisted optimization.Scientific reports · 2025Article
- Impact of Fomes fomentarius growth on the mechanical properties of material extrusion additively manufactured PLA and PLA/Hemp biopolymers.Fungal biology and biotechnology · 2025Article
- Uncovering the transcriptional landscape of Fomes fomentarius during fungal-based material production through gene co-expression network analysis.Fungal biology and biotechnology · 2025Article
- Review on mushroom mycelium-based products and their production process: from upstream to downstream.Bioresources and bioprocessing · 2025Review
- Tailoring the Mechanical Properties of Fungal Mycelium Mats with Material Extrusion Additive Manufacturing of PHBH and PLA Biopolymers.ACS omega · 2024Article
- A Comprehensive Review on Studying and Developing Guidelines to Standardize the Inspection of Properties and Production Methods for Mycelium-Bound Composites in Bio-Based Building Material Applications.Biomimetics (Basel, Switzerland) · 2024Review
- Article
- Improving the Physical and Mechanical Properties of Mycelium-Based Green Composites Using Paper Waste.Polymers · 2024Article
- Article
- Mechanical, physical and thermal properties of composite materials produced with the basidiomycete Fomes fomentarius.Fungal biology and biotechnology · 2023Article
- Wood-Decaying Fungi: From Timber Degradation to Sustainable Insulating Biomaterials Production.Materials (Basel, Switzerland) · 2023Article
- The complex structure ofScience advances · 2023Article
- Mechanical, Physical, and Chemical Properties of Mycelium-Based Composites Produced from Various Lignocellulosic Residues and Fungal Species.Journal of fungi (Basel, Switzerland) · 2022Article
- Fungi in Mycelium-Based Composites: Usage and Recommendations.Materials (Basel, Switzerland) · 2022Review
- Amazing Fungi for Eco-Friendly Composite Materials: A Comprehensive Review.Journal of fungi (Basel, Switzerland) · 2022Review
- Connecting materials sciences with fungal biology: a sea of possibilities.Fungal biology and biotechnology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFilamentous fungi of the phylum Basidiomycota are considered as an attractive source for the biotechnological production of composite materials. The ability of many basidiomycetes to accept residual lignocellulosic plant biomass from agriculture and forestry such as straw, shives and sawdust as substrates and to bind and glue together these otherwise loose but reinforcing substrate particles into their mycelial network, makes them ideal candidates to produce biological composites to replace petroleum-based synthetic plastics and foams in the near future.
resultsHere, we describe for the first time the application potential of the tinder fungus Fomes fomentarius for lab-scale production of mycelium composites. We used fine, medium and coarse particle fractions of hemp shives and rapeseed straw to produce a set of diverse composite materials and show that the mechanical materials properties are dependent on the nature and particle size of the substrates. Compression tests and scanning electron microscopy were used to characterize composite material properties and to model their compression behaviour by numerical simulations. Their properties were compared amongst each other and with the benchmark expanded polystyrene (EPS), a petroleum-based foam used for thermal isolation in the construction industry. Our analyses uncovered that EPS shows an elastic modulus of 2.37 ± 0.17 MPa which is 4-times higher compared to the F. fomentarius composite materials whereas the compressive strength of 0.09 ± 0.003 MPa is in the range of the fungal composite material. However, when comparing the ability to take up compressive forces at higher strain values, the fungal composites performed better than EPS. Hemp-shive based composites were able to resist a compressive force of 0.2 MPa at 50% compression, rapeseed composites 0.3 MPa but EPS only 0.15 MPa.
conclusionThe data obtained in this study suggest that F. fomentarius constitutes a promising cell factory for the future production of fungal composite materials with similar mechanical behaviour as synthetic foams such as EPS. Future work will focus on designing materials characteristics through optimizing substrate properties, cultivation conditions and by modulating growth and cell wall composition of F. fomentarius, i.e. factors that contribute on the meso- and microscale level to the composite behaviour.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.